News headlines about Strata Skin Sciences (NASDAQ:SSKN) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Strata Skin Sciences earned a daily sentiment score of 0.08 on Accern’s scale. Accern also assigned media stories about the medical device company an impact score of 46.5030745454451 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news articles that may have effected Accern’s scoring:
- STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Results of Operations and Financial Condition (4-traders.com)
- Edited Transcript of SSKN earnings conference call or presentation 9-Nov-17 9:30pm GMT (finance.yahoo.com)
- STRATA Skin Sciences’ (SSKN) CEO Frank McCaney on Q3 2017 Results – Earnings Call Transcript (seekingalpha.com)
- Strata Skin Sciences, Inc. (SSKN) Price Target Cut to $7.00 (americanbankingnews.com)
- STRATA Skin Sciences Reports Third Quarter 2017 Financial Results (finance.yahoo.com)
A number of equities research analysts have recently commented on SSKN shares. HC Wainwright set a $12.00 target price on Strata Skin Sciences and gave the company a “buy” rating in a research report on Friday, August 11th. Zacks Investment Research cut Strata Skin Sciences from a “hold” rating to a “sell” rating in a research report on Wednesday, August 16th. Finally, ValuEngine upgraded Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.
Shares of Strata Skin Sciences (SSKN) opened at $1.30 on Wednesday. Strata Skin Sciences has a 12-month low of $1.06 and a 12-month high of $5.40. The company has a debt-to-equity ratio of 1.85, a quick ratio of 0.93 and a current ratio of 1.34.
ILLEGAL ACTIVITY NOTICE: “Strata Skin Sciences (SSKN) Getting Somewhat Positive Press Coverage, Accern Reports” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://sportsperspectives.com/2017/11/15/strata-skin-sciences-sskn-getting-somewhat-positive-press-coverage-accern-reports.html.
About Strata Skin Sciences
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.